| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 46.89 | 36 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.889 | 36 |
| GSM780709 | Untreated after 4 days (C3_1) | 46.3846 | 34 |
| GSM780719 | Untreated after 4 days (C1_2) | 50.5109 | 50 |
| GSM780720 | Untreated after 4 days (C2_2) | 44.9957 | 27 |
| GSM780721 | Untreated after 4 days (C3_2) | 44.1852 | 23 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 48.6272 | 44 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 41.8482 | 13 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 47.9551 | 41 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 50.4021 | 50 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 45.1946 | 28 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 36.9813 | 1 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 47.7802 | 40 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 47.7533 | 40 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 49.4154 | 47 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 48.3734 | 43 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 44.2849 | 24 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 48.0377 | 41 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 43.9041 | 22 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 42.54 | 15 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 48.0831 | 41 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 41.9947 | 13 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 49.4032 | 46 |